QT Imaging (NASDAQ:QTI – Get Free Report) and Inogen (NASDAQ:INGN – Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, valuation, dividends, analyst recommendations and risk.
Analyst Recommendations
This is a breakdown of recent recommendations and price targets for QT Imaging and Inogen, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| QT Imaging | 1 | 1 | 2 | 0 | 2.25 |
| Inogen | 1 | 0 | 0 | 1 | 2.50 |
QT Imaging currently has a consensus price target of $8.00, suggesting a potential upside of 231.95%. Given QT Imaging’s higher possible upside, equities analysts plainly believe QT Imaging is more favorable than Inogen.
Risk and Volatility
QT Imaging has a beta of 0.02, meaning that its stock price is 98% less volatile than the S&P 500. Comparatively, Inogen has a beta of 1.5, meaning that its stock price is 50% more volatile than the S&P 500.
Institutional and Insider Ownership
24.2% of QT Imaging shares are owned by institutional investors. Comparatively, 89.9% of Inogen shares are owned by institutional investors. 25.4% of QT Imaging shares are owned by company insiders. Comparatively, 2.5% of Inogen shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Profitability
This table compares QT Imaging and Inogen’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| QT Imaging | -77.25% | -1,202.69% | -46.76% |
| Inogen | -6.94% | -13.17% | -8.36% |
Valuation and Earnings
This table compares QT Imaging and Inogen”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| QT Imaging | $18.92 million | 1.75 | -$21.08 million | ($1.57) | -1.54 |
| Inogen | $354.30 million | 0.47 | -$22.75 million | ($0.90) | -6.97 |
QT Imaging has higher earnings, but lower revenue than Inogen. Inogen is trading at a lower price-to-earnings ratio than QT Imaging, indicating that it is currently the more affordable of the two stocks.
Summary
Inogen beats QT Imaging on 9 of the 15 factors compared between the two stocks.
About QT Imaging
QT Imaging Holdings, Inc. engages in the research, development, and commercialization of body imaging systems for detection, diagnosis, monitoring, and treatment of diseases. The company offers QT Ultrasound Breast Scanner, an ultrasonic imaging system that provides reflection-mode and transmission-mode images of a patient’s breast. QT Imaging Holdings, Inc. was founded in 2011 and is based in Novato, California.
About Inogen
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.
Receive News & Ratings for QT Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for QT Imaging and related companies with MarketBeat.com's FREE daily email newsletter.
